J Korean Dent Soc Anesthesiol.  2013 Sep;13(3):89-94. 10.17245/jkdsa.2013.13.3.89.

EC50 of Remifentanil to Prevent Propofol Injection Pain

Affiliations
  • 1Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Busan, Korea. dryoonji@pusan.ac.kr
  • 2Department of Anesthesia and Pain Medicine School of Medicine, Pusan National University, Busan, Korea.
  • 3Department of Oral and Maxillofacial Surgery School of Dentistry, Pusan National University, Busan, Korea.

Abstract

BACKGROUND
Various strategies have been studied to reduce the propofol injection pain. This study was designed to find out effect-site target concentration (Ce) of remifentanil at which there was a 50% probability of preventing the propofol injection pain (EC50).
METHODS
Anesthesia was induced with a remifentanil TCI (Minto model). The Ce of remifentanil for the first patient started from 2.0 ng/ml. The Ce of remifentanil for each subsequent patient was determined by the response of the previous patient by Dixon up-and-down method with the interval of 0.5 ng/ml. After the remifentanil reached target concentrations, propofol was administered via a target-controlled infusion system based on a Marsh pharmacokinetic model using a TCI device (Orchestra®; Fresenius-Vial, Brezins, France). The dose of propofol was effect site target-controlled infusion (TCI) of 3 µg/ml.
RESULTS
The EC50 of remifentanil to prevent the propofol injection pain was 1.80 ± 0.35 ng/ml by Dixon's up and down method.
CONCLUSIONS
The EC50 of remifentanil to blunt the pain responses to propofol injection was 1.80 ± 0.35 ng/ml for propofol TCI anesthesia.

Keyword

Injection; Pain; Propofol; Remifentanil

MeSH Terms

Anesthesia
Humans
Methods
Propofol*
Wetlands
Propofol
Full Text Links
  • JKDSA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr